William Anderson - Roche Holding Chief Pharmaceuticals

RO Stock  CHF 269.60  3.80  1.43%   

Insider

William Anderson is Chief Pharmaceuticals of Roche Holding AG
Age 57
Phone41 61 688 11 11
Webhttps://www.roche.com

Roche Holding Management Efficiency

The company has return on total asset (ROA) of 0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Roche Holding AG has accumulated 22.28 B in total debt with debt to equity ratio (D/E) of 1.0, which is about average as compared to similar companies. Roche Holding AG has a current ratio of 1.09, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Roche Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Roche Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Roche Holding AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Roche to invest in growth at high rates of return. When we think about Roche Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Laurent FreixeNestl SA
61
Ericson ChanZurich Insurance Group
57
Mario GrecoZurich Insurance Group
64
Tulsi NaiduZurich Insurance Group
50
Karen HaleNovartis AG
55
Stefan PalzerNestl SA
54
Marco SettembriNestl SA
64
MBA MBANestl SA
54
Constance WardLonza Group AG
N/A
David RennieNestl SA
57
Ulf SchneiderNestl SA
58
Jeffrey DaileyZurich Insurance Group
66
Guido FurerSwiss Re AG
60
Mark SenkevicsSwiss Re AG
N/A
MBA BSZurich Insurance Group
53
Jennifer ClancyLonza Group AG
N/A
Harry KirschNovartis AG
58
Thomas BohunSwiss Re AG
N/A
Robert PharmDNovartis AG
55
Cathy DesquessesSwiss Re AG
50
Steffen LangNovartis AG
56
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE I operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 100920 people. Roche Holding AG (RO) is traded on SIX Swiss Exchange in Switzerland and employs 103,613 people.

Management Performance

Roche Holding AG Leadership Team

Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Claudia Bockstiegel, G Counsel
Barbara Schadler, Head Communications
Johannes MD, Head Devel
Bruno Eschli, Head Relations
Thomas Schinecker, Chief Diagnostics
Cristina Wilbur, Chief Officer
William Anderson, Chief Pharmaceuticals
Alan Hippe, Chief Officer
Severin Schwan, CEO Director
Pascale Schmidt, Chief Officer

Roche Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Roche Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Roche Stock Analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.